Bluejay Diagnostics, Inc. Public Float
Bluejay Diagnostics, Inc. (BJDX) had Public Float of $2.57 million as of 2025-06-30, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-06
- 2025-06-30: Entity Public Float $2.57M.
- 2024-06-30: Entity Public Float $1.70M.
- 2023-06-30: Entity Public Float $3.03M.
- 2022-06-30: Entity Public Float $21.36M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.57M 10-K · filed 2026-03-06 |
| 2024-06-30 | $1.70M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $3.03M 10-K · filed 2024-03-28 |
| 2022-06-30 | $21.36M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |